2024
DOI: 10.3389/fphar.2024.1488725
|View full text |Cite
|
Sign up to set email alerts
|

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline

Michele Fusaroli,
Francesco Salvo,
Charles Khouri
et al.

Abstract: Disproportionality analyses are the most-commonly used study design used in the post-marketing phase to detect suspected adverse drug reactions in individual case safety reports. Recent years have witnessed an exponential increase in published articles on disproportionality analyses, thanks to publicly accessible databases. Unfortunately, this trend was accompanied by concerns on lack of transparency and misinterpretation of results, both generating unjustified alarm and diluting true signals into overwhelming… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 47 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?